REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 219 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.
External links
This page lists REATA PHARMACEUTICALS INC's shareholders in Q2 2023. To view REATA PHARMACEUTICALS INC's shareholder history, click here.